These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
962 related articles for article (PubMed ID: 23665154)
21. The ubiquitin-proteasome system and skeletal muscle wasting. Attaix D; Ventadour S; Codran A; Béchet D; Taillandier D; Combaret L Essays Biochem; 2005; 41():173-86. PubMed ID: 16250905 [TBL] [Abstract][Full Text] [Related]
22. Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy. Sandri M Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1291-7. PubMed ID: 20089936 [TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of skeletal muscle atrophy in a mouse model of cerebral ischemia. Desgeorges MM; Devillard X; Toutain J; Divoux D; Castells J; Bernaudin M; Touzani O; Freyssenet DG Stroke; 2015 Jun; 46(6):1673-80. PubMed ID: 25953371 [TBL] [Abstract][Full Text] [Related]
24. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways. Voisin L; Breuillé D; Combaret L; Pouyet C; Taillandier D; Aurousseau E; Obled C; Attaix D J Clin Invest; 1996 Apr; 97(7):1610-7. PubMed ID: 8601625 [TBL] [Abstract][Full Text] [Related]
25. FoxO Transcription Factors Are Critical Regulators of Diabetes-Related Muscle Atrophy. O'Neill BT; Bhardwaj G; Penniman CM; Krumpoch MT; Suarez Beltran PA; Klaus K; Poro K; Li M; Pan H; Dreyfuss JM; Nair KS; Kahn CR Diabetes; 2019 Mar; 68(3):556-570. PubMed ID: 30523026 [TBL] [Abstract][Full Text] [Related]
26. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle. Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784 [TBL] [Abstract][Full Text] [Related]
27. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Zhao J; Brault JJ; Schild A; Cao P; Sandri M; Schiaffino S; Lecker SH; Goldberg AL Cell Metab; 2007 Dec; 6(6):472-83. PubMed ID: 18054316 [TBL] [Abstract][Full Text] [Related]
28. Guava leaf extract attenuated muscle proteolysis in dexamethasone induced muscle atrophic mice via ubiquitin proteasome system, mTOR-autophagy, and apoptosis pathway. Lee H; Eo Y; Kim SY; Lim Y Nutr Res; 2024 Jul; 127():97-107. PubMed ID: 38909568 [TBL] [Abstract][Full Text] [Related]
29. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential. Han HQ; Zhou X; Mitch WE; Goldberg AL Int J Biochem Cell Biol; 2013 Oct; 45(10):2333-47. PubMed ID: 23721881 [TBL] [Abstract][Full Text] [Related]
30. Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents. Ringseis R; Keller J; Lukas I; Spielmann J; Most E; Couturier A; König B; Hirche F; Stangl GI; Wen G; Eder K Biochim Biophys Acta; 2013 Jan; 1830(1):2105-17. PubMed ID: 23041501 [TBL] [Abstract][Full Text] [Related]
31. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction. Schulze PC; Fang J; Kassik KA; Gannon J; Cupesi M; MacGillivray C; Lee RT; Rosenthal N Circ Res; 2005 Sep; 97(5):418-26. PubMed ID: 16051886 [TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways. Doyle A; Zhang G; Abdel Fattah EA; Eissa NT; Li YP FASEB J; 2011 Jan; 25(1):99-110. PubMed ID: 20826541 [TBL] [Abstract][Full Text] [Related]
33. Implication of altered ubiquitin-proteasome system and ER stress in the muscle atrophy of diabetic rats. Reddy SS; Shruthi K; Prabhakar YK; Sailaja G; Reddy GB Arch Biochem Biophys; 2018 Feb; 639():16-25. PubMed ID: 29277369 [TBL] [Abstract][Full Text] [Related]
34. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. Paul PK; Gupta SK; Bhatnagar S; Panguluri SK; Darnay BG; Choi Y; Kumar A J Cell Biol; 2010 Dec; 191(7):1395-411. PubMed ID: 21187332 [TBL] [Abstract][Full Text] [Related]
36. Time course of ubiquitin-proteasome and macroautophagy-lysosome pathways in skeletal muscle in rats with heart failure. Fujita N; Fujino H; Sakamoto H; Takegaki J; Deie M Biomed Res; 2015; 36(6):383-92. PubMed ID: 26700592 [TBL] [Abstract][Full Text] [Related]
37. Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammation. Schakman O; Dehoux M; Bouchuari S; Delaere S; Lause P; Decroly N; Shoelson SE; Thissen JP Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E729-39. PubMed ID: 22739109 [TBL] [Abstract][Full Text] [Related]
38. Is there a common mechanism linking muscle wasting in various disease types? Tisdale MJ Curr Opin Support Palliat Care; 2007 Dec; 1(4):287-92. PubMed ID: 18685377 [TBL] [Abstract][Full Text] [Related]
39. Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins. Lokireddy S; Mouly V; Butler-Browne G; Gluckman PD; Sharma M; Kambadur R; McFarlane C Am J Physiol Cell Physiol; 2011 Dec; 301(6):C1316-24. PubMed ID: 21900687 [TBL] [Abstract][Full Text] [Related]